0202/8/8
2000 ‫ מאמרים לבחינת שלב א' בגסטרואנטרולוגיה נובמבר‬:‫הנדון‬
‫ לא תהיינה שאלות ממאמרים‬. '‫ שאלות בבחינה שלב א‬/8-/1 ‫מצורפת רשימת המאמרים שמתוכם תהיינה כ‬
.‫אחרים אלא מתוך ספר החובה של הבחינה‬
1)
2)
3)
4)
5)
6)
7)
8)
9)
10)
11)
12)
13)
14)
15)
16)
17)
18)
19)
20)
Hereditary and familial colon cancer. Gastroenterology 2010;138:2044-58
Microsatellite instability in colon cancer. Gastroenterology 2010;138:2073-87
Progress and challenges in colorectal screening and surveillance.
Gastroenterology 2010;138:2115-26
Budd-Chiari syndrome and veno-occlusive disease /sinusoidal obstruction syndrome.
Gut 2008;57:1469-1478
Acute kidney injury in cirrhosis. Hepatology 2008;48:2064-2077.
Systemic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome.
Hepatology 201;51:576-584.
Radiofrequency ablation- great for some or justified for many? NEJM 2009;360:2353-2355.
History, molecular mechanisms and endoscopic treatment for Barrett's esophagus.
Gastroenterology 2010;138:854-69 (‫(במאמר סקירה זה רק החלק של הטיפול האנדוסקופי נדרש לבחינה‬
Genetic risk factors for post-infectious irritable bowel sundrome following a waterborne
outbreak of gastroenteritis. Gastroenterology 2010;138:1502-1513.
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systemic review.
Gut 2010;59:325-332.
IL-28B polymorphism imporves viral kinetics and is the strongest pretreatment predictor of
sustained virologic response in genotype 1 hepatitis C virus.
Gastroenterology 2010;139:120-129.
AASLD practice guidelines HCV. Hepatology 2009;49:1335-1374.
AASLD practice guidelines HBV. Hepatology September 2009 .
EASL clinical practice guidelines: management of chronic hepatitis B.
Hepatology 2009;50:227-242.
AGA medical position statement on the diagnosis and management of colorectal neoplasia in
IBD. Gastroenterology 2010;138:738-745.
Long term safety of infliximab for the treatment of IBD: a single center cohort study.
Gut 2009;58:501- 508.
Quality indicators for colonoscopy and the risk of interval cancer. NEJM 2010;362:1795-803.
SONIC study: Infliximab, azathioprine or combination therapy for Crohn's disease.
NEJM 2010;362:1383-95.
Predicting the response to infliximab from trough serum levels. Gut 2010; 59:7-8.
Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in
Acute ulcerative colitis. Gut 2010;59:49-54.
‫שנה טובה‬
‫פרופ שירין‬